By modulating the antioxidant systems, cellular metabolism, and the remodeling of extracellular matrix, TXNIP exerts tumor suppressive activities in various human cancers such as colorectal, liver, breast, and lung carcinomas and hematologic malignancies, including AML [33, 34, 35, 36]. The gene discussed is TXNIP; the disease is cancer.